93 related articles for article (PubMed ID: 25757918)
21. The antitumor effects of methyl-β-cyclodextrin against primary effusion lymphoma via the depletion of cholesterol from lipid rafts.
Gotoh K; Kariya R; Alam MM; Matsuda K; Hattori S; Maeda Y; Motoyama K; Kojima A; Arima H; Okada S
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):285-9. PubMed ID: 25446086
[TBL] [Abstract][Full Text] [Related]
22. Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate.
Salmaso S; Semenzato A; Caliceti P; Hoebeke J; Sonvico F; Dubernet C; Couvreur P
Bioconjug Chem; 2004; 15(5):997-1004. PubMed ID: 15366952
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.
Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846
[TBL] [Abstract][Full Text] [Related]
24. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
25. Sustained release of flufenamic acid from a drug-triacetyl-beta-cyclodextrin complex.
Nakanishi K; Masukawa T; Nadai T; Yoshii K; Okada S; Miyajima K
Biol Pharm Bull; 1997 Jan; 20(1):66-70. PubMed ID: 9013809
[TBL] [Abstract][Full Text] [Related]
26. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
Arima H; Yunomae K; Hirayama F; Uekama K
J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of dimethylacetyl-beta-cyclodextrin on lipopolysaccharide-induced macrophage activation and endotoxin shock in mice.
Arima H; Motoyama K; Matsukawa A; Nishimoto Y; Hirayama F; Uekama K
Biochem Pharmacol; 2005 Nov; 70(10):1506-17. PubMed ID: 16214116
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticles of folic acid-methyl-β-cyclodextrin (FA-MβCD)/adamantane-albumin exhibit enhanced antitumor activity compared with FA-MβCD alone.
Sakai A; Yamashita Y; Misumi S; Kishimoto N; Onodera R; Higashi T; Arima H; Motoyama K
FEBS Open Bio; 2023 Feb; 13(2):233-245. PubMed ID: 36537756
[TBL] [Abstract][Full Text] [Related]
29. Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery.
Zhang H; Cai Z; Sun Y; Yu F; Chen Y; Sun B
J Biomed Mater Res A; 2012 Sep; 100(9):2441-9. PubMed ID: 22566147
[TBL] [Abstract][Full Text] [Related]
30. Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors.
Arima H; Motoyama K; Higashi T
Adv Drug Deliv Rev; 2013 Aug; 65(9):1204-14. PubMed ID: 23602906
[TBL] [Abstract][Full Text] [Related]
31. Anticancer activity of released doxorubicin from a folate-mediated polyelectrolyte complex.
Chiu CC; Lin YT; Sun SL; Sung KH; Wang LF
J Biomater Sci Polym Ed; 2011; 22(11):1487-507. PubMed ID: 20626956
[TBL] [Abstract][Full Text] [Related]
32. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
Leamon CP; Reddy JA; Vetzel M; Dorton R; Westrick E; Parker N; Wang Y; Vlahov I
Cancer Res; 2008 Dec; 68(23):9839-44. PubMed ID: 19047164
[TBL] [Abstract][Full Text] [Related]
33. Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug.
Zhao F; Yin H; Li J
Biomaterials; 2014 Jan; 35(3):1050-62. PubMed ID: 24189097
[TBL] [Abstract][Full Text] [Related]
34. The therapeutic efficiency of FP-PEA/TAM67 gene complexes via folate receptor-mediated endocytosis in a xenograft mice model.
Arote RB; Hwang SK; Lim HT; Kim TH; Jere D; Jiang HL; Kim YK; Cho MH; Cho CS
Biomaterials; 2010 Mar; 31(8):2435-45. PubMed ID: 20022105
[TBL] [Abstract][Full Text] [Related]
35. Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin-Preparation and in vitro and in vivo evaluation.
Pathak SM; Musmade P; Dengle S; Karthik A; Bhat K; Udupa N
Eur J Pharm Sci; 2010 Nov; 41(3-4):440-51. PubMed ID: 20656025
[TBL] [Abstract][Full Text] [Related]
36. The antitumor effect of folic acid conjugated-Auricularia auricular polysaccharide-cisplatin complex on cervical carcinoma cells in nude mice.
Qiu J; Zhang H; Wang Z; Liu D; Liu S; Han W; Regenstein JM; Geng L
Int J Biol Macromol; 2018 Feb; 107(Pt B):2180-2189. PubMed ID: 29132812
[TBL] [Abstract][Full Text] [Related]
37. Preparation, characterization, and sonodynamic antitumor effect of the folate receptor targeted FA-EN-β-CD containing hematoporphyrin in vitro.
Wang C; Du F
Drug Dev Res; 2020 Aug; 81(5):585-592. PubMed ID: 32163191
[TBL] [Abstract][Full Text] [Related]
38. Gene delivery to tumor cells by cationic polymeric nanovectors coupled to folic acid and the cell-penetrating peptide octaarginine.
Jiang QY; Lai LH; Shen J; Wang QQ; Xu FJ; Tang GP
Biomaterials; 2011 Oct; 32(29):7253-62. PubMed ID: 21715001
[TBL] [Abstract][Full Text] [Related]
39. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
Arima H; Yoshimatsu A; Ikeda H; Ohyama A; Motoyama K; Higashi T; Tsuchiya A; Niidome T; Katayama Y; Hattori K; Takeuchi T
Mol Pharm; 2012 Sep; 9(9):2591-604. PubMed ID: 22873579
[TBL] [Abstract][Full Text] [Related]
40. Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells.
Arima H; Arizono M; Higashi T; Yoshimatsu A; Ikeda H; Motoyama K; Hattori K; Takeuchi T; Hirayama F; Uekama K
Cancer Gene Ther; 2012 May; 19(5):358-66. PubMed ID: 22402627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
